Guardian Research Network® and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer Joint effort recognizes combined missions to support… CONTINUE
New Research to be Presented at AAAAI 2022 on Hereditary Angioedema
ThinkGenetic is proud to announce a recent collaborative research project will be presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting this February 25-29th in… CONTINUE
Massachusetts Startup Wins Horizon Prize, Powered by MIT Solve, with Algorithm-Based FindEHR Solution for Finding Undiagnosed Genetic Disorder Patients using Electronic Medical Records
ThinkGenetic combines modern machine learning with practical information in genetics to solve a major concern in healthcare – the identification of patients living with undiagnosed rare genetic conditions Boston, MA,… CONTINUE
Horizon Therapeutics Announces ThinkGenetic Curated Algorithms as Winning Solution of First-Ever Horizon Prize, Powered by MIT Solve, to Accelerate Rare Disease Diagnosis
PRESS RELEASE – Source: Horizon Therapeutics plc Horizon Therapeutics plc Announces New Genetic Counselor Curated Algorithms and Next-Generation Sequencing Data as Winning Solutions of First-Ever Horizon Prize, Powered by MIT… CONTINUE
Ochsner Lafayette Healthcare Innovation Fund Invests in ThinkGenetic Vision for Genetic Disease Identification in Local Patients
LAFAYETTE, La., April 20, 2021 (Newswire.com) – Today ThinkGenetic, Inc. (thinkgenetic.com) announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund. “After years of working… CONTINUE
MetroWest Daily News: Sudbury startup aids in diagnosing genetic conditions
Original article: https://www.metrowestdailynews.com/news/20190307/sudbury-startup-aids-in-diagnosing-genetic-conditions By Zane Razzaq Daily News staff SUDBURY – With the average patient struggling to find a diagnosis for a genetic condition for several years, a Sudbury family is… CONTINUE
Big News for ThinkGenetic Supporters – Angel Funding Round is Closed
In a very exciting announcement from the news desk, ThinkGenetic announced the closure of its $1.5M Angel Funding round. (See the full announcement here.) When asked about the incredible accomplishment,… CONTINUE
ThinkGenetic Provided $100,000 Credit from Amazon Web Services as Part of MassChallenge
ThinkGenetic is excited to announce that Amazon Web Services, Inc. (AWS), a subsidiary of Amazon.com, Inc., has approved ThinkGenetic into it’s AWS Activate program. Amazon Web Services provides startups with… CONTINUE
ThinkGenetic Supports Rare Disease Day – Show Your Rare
ThinkGenetic is proud to support Rare Disease Day. Why? Because we’re a part of your community! We live and breathe the struggles and triumphs firsthand. Do you know the ThinkGenetic… CONTINUE
Connecting, Collaborating, and Activating at the Vibrant 2017 RARE Patient Advocacy Summit
While many of our ThinkGenetic teammates helped others “harness their inner power” at the National Society of Genetic Counselors Annual Conference in Columbus, Ohio, ThinkGenetic CEO, Dave Jacob and I… CONTINUE
Harnessing the Power Within at the 2017 National Society of Genetic Counselors Annual Conference
Have you ever been able to achieve something you never thought possible, yet when you look back you realize that you always had the power to do it? Maybe someone… CONTINUE
ThinkGenetic CEO “Disruptor” to Discuss the Patient Perspective of Advancing Clinical Trials
ThinkGenetic CEO, Dave Jacob, is honored to be an invited speaker during the “Ask the Patient” discussions taking place during meals and breaks at the 7th annual DPharm: Disruptive Innovations… CONTINUE
ThinkGenetic to Engage with Rare Disease Community at Global Genes’ 6th Annual RARE Patient Advocacy Summit
ThinkGenetic, Inc. is delighted to be participating in the 6th Annual RARE Patient Advocacy Summit and Partnering and Investor Forum to further its mission of empowering the rare disease community… CONTINUE
TRNDS Panel: Virtual Visits to Facilitate the Conduct of Feasible Clinical Trials
ThinkGenetic CEO and Founder, Dave Jacob, will be a part of an impressive panel this week, discussing ways in which technology can help to facilitate clinical trials participation. The Technology &… CONTINUE
ThinkGenetic to Attend and Exhibit at 13th Annual WORLDSymposium™
ThinkGenetic is excited to be heading to sunny San Diego, California this February to participate in the annual Lysosomal Disease Network WORLDSymposium. The Symposium is an interdisciplinary forum to explore,… CONTINUE
Davalen Spawns ThinkGenetic and Exits the Consulting Services Market
After 10 years as an IBM premier partner of consulting services in the collaborative solutions market, the Davalen LLC team has moved on to helping people living with genetic conditions. … CONTINUE
ThinkGenetic in 2016: A Message from the President
Preparing for this article on a year in the life of ThinkGenetic required the collection of statistics about financial and content contributors, website visitors, research and development activities, and partner… CONTINUE
ThinkGenetic to Attend the 35th Annual J.P. Morgan Healthcare Conference
Dave Jacob, Chief Executive Officer and Dawn Jacob Laney, MS, CGC, CCRC, Founder of ThinkGenetic, Inc., will be attending the 35th Annual J.P. Morgan Healthcare Conference on January 9 – 12, 2017 at… CONTINUE
ThinkGenetic Signs First International Advocacy Partner
France based support group, Cutis Laxa Internationale, becomes first International ThinkGenetic Advocacy Partner Cutis Laxa Internationale became an official ThinkGenetic Advocacy Partner today, the first advocacy partner based outside the… CONTINUE
Why My Kindred Spirit is a Rock Star
At first glance, it may not seem Austin Carlile, the front-man of the metal-core band Of Mice & Men and I have much in common. We grew up about 100… CONTINUE
6th Annual Fabry Family Medical Conference
On September 8-9, 2016 in Greensboro, North Carolina the National Fabry Disease Foundation (NFDF) will be hosting it’s annual Fabry Family Medical Conference. An important event for all individuals with Fabry disease… CONTINUE
Commissioning IBM Watson™ for Genetic Disease
Sometimes your next business adventure comes from the most unlikely of situations. Like many small business owners, Len Barker found himself diving into a new pool of opportunity after being… CONTINUE
ThinkGenetic Father Hopes to Revolutionize Genetic Information on the Internet
Like many other people with a genetic disease, Dave Jacob did not learn that his childhood heart defect was related to an underlying genetic mutation until it was uncovered he… CONTINUE
Frequently Asked Question: Will the Site Contain Information in Other Languages than English?
As we spread the news about ThinkGenetic we come across those who have questions about this exciting project. Especially questions around how individuals, groups, organizations and advocates can get involved!… CONTINUE
Frequently Asked Questions: How Can Parents Be Involved?
As we spread the news about ThinkGenetic we love to chat with the community and answer any questions about our exciting site. As these questions come in we like to share… CONTINUE
Ready for Life Science Fast Track 2016 by The Capital Network?
Co-Founders Dave Jacob and Len Barker will be attending the Life Sciences Fast Track 2016 on Thursday, February 25, 2016 from 9:00 AM to 4:30 PM at the Nutter McClennen &… CONTINUE
Video: Why ThinkGenetic is the Best New Innovation in Pediatric Healthcare
ThinkGenetic is a labor of love between ThinkGenetic, Inc., Emory University’s Department of Human Genetics and IBM. Supported by International Advocacy groups like The Legacy of Angels, NORD and Genetic… CONTINUE
ThinkGenetic to Exhibit with Emory Genetics Laboratory at WORLDSymposium™
ThinkGenetic, Inc., is proud to be exhibiting alongside Emory Genetics Laboratory at the Manchester Grand Hyatt San Diego the week of February 29 – March 4, 2016 to demonstrate the beta of ThinkGenetic. This… CONTINUE
IBM and ThinkGenetic Sign Commercial Agreement to Use Watson
After a rigorous review of the ThinkGenetic business plan, IBM signed a commercial agreement allowing the use of Watson in the ThinkGenetic product. Using expertise in information science, library science… CONTINUE